Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content

Tessa P. Sandberg; Jan Oosting; Gabi W. van Pelt; Wilma E. Mesker; Rob A.E.M. Tollenaar; Hans Morreau

doi:10.18632/oncotarget.26820

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Errata:

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content

PDF | How to cite

Oncotarget. 2019; 10:2416-2416. https://doi.org/10.18632/oncotarget.26820

Metrics: PDF 1545 views | ?

Tessa P. Sandberg^1,2, Jan Oosting¹, Gabi W. van Pelt², Wilma E. Mesker², Rob A.E.M. Tollenaar² and Hans Morreau¹

¹ Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
² Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands

Published: March 22, 2019

This article has been corrected: During production, 'The upregulation of THBS2, COX7A1 and LGALS1/galectin-1' was placed twice in the Abstract section. The duplicate line has been deleted and the proper Abstract is shown below.

ABSTRACT

The tumor microenvironment is a dominant determinant of cancer cell behavior. Reactive tumor stroma is associated with poor outcome perspective. The tumor- stroma ratio (TSR) is a strong independent prognostic factor in colorectal cancer and is easily assessed using conventional hematoxylin and eosin (H&E) stained paraffin sections at the invasive margin of the tumor. We aim to understand the biology of the tumor stroma in colorectal cancer by investigating the transcriptomic profiles of tumors classified by the TSR method. The TSR was assessed in a cohort of 71 colorectal cancer patients undergoing surgery without (neo)adjuvant therapy. In the cohort, stroma-high tumors were distinguished from stroma-low tumors at gene expression level in the upregulation of biological pathways related to extracellular matrix (ECM) remodeling and myogenesis. The activated microenvironment in stroma- high tumors overexpressed different types of collagen genes, THBS2 and 4 as well as INHBA, COX71A and LGALS1/galectin-1. The upregulation of THBS2, COX7A1 and LGALS1/galectin-1 in stroma-high tumors was validated in The Cancer Genome Atlas. In conclusion, the gene expression data reflects the high stromal content of tumors assessed based on the histological method, the TSR. The composition of the microenvironment suggests an altered proteolysis resulting in ECM remodeling and invasive capacity of tumor cells.

Original article: Oncotarget. 2018; 9:31502-31515. DOI: https://doi.org/10.18632/oncotarget.25845.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26820

Publication Alerts

Post-Publication Promotion

Publication Discount

Errata:

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content